Exponent (EXPO) Stock Forecast, Price Target & Predictions
EXPO Stock Forecast
Exponent stock forecast is as follows: an average price target of $104.00 (represents a 14.70% upside from EXPO’s last price of $90.67) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
EXPO Price Target
The average price target for Exponent (EXPO) is $104.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $120.00 to $88.00. This represents a potential 14.70% upside from EXPO's last price of $90.67.
EXPO Analyst Ratings
According to 1 Wall Street analysts, Exponent's rating consensus is 'Hold'. The analyst rating breakdown for EXPO stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Exponent Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | Tobey Sommer | Truist Financial | $120.00 | $105.54 | 13.70% | 32.35% |
| Jun 26, 2024 | Joshua Chan | UBS | $88.00 | $94.44 | -6.82% | -2.94% |
The latest Exponent stock forecast, released on Jul 26, 2024 by Tobey Sommer from Truist Financial, set a price target of $120.00, which represents a 13.70% increase from the stock price at the time of the forecast ($105.54), and a 32.35% increase from EXPO last price ($90.67).
Exponent Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $104.00 |
| Last Closing Price | $90.67 | $90.67 | $90.67 |
| Upside/Downside | -100.00% | -100.00% | 14.70% |
In the current month, the average price target of Exponent stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Exponent's last price of $90.67. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 26, 2024 | UBS | Neutral | Neutral | Hold |
Exponent's last stock rating was published by UBS on Jun 26, 2024. The company gave EXPO a "Neutral" rating, the same as its previous rate.
Exponent Financial Forecast
Exponent Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $236.77M | $133.34M | - | $140.31M | $127.36M | $127.18M | $130.28M | $128.48M | $113.51M | $116.41M | $119.88M | $116.48M | $110.11M | $98.66M | $92.05M | $105.95M | - | $101.55M |
| Avg Forecast | $145.00M | $153.00M | $150.00M | $145.00M | $129.48M | $138.04M | $139.06M | $136.93M | $119.59M | $125.66M | $130.83M | $125.98M | $119.11M | $126.39M | $130.40M | $127.12M | $111.45M | $114.00M | $118.53M | $115.00M | $102.15M | $104.13M | $106.05M | $102.80M | $90.75M | $92.80M | $87.33M | $100.40M | $97.11M | $97.25M |
| High Forecast | $145.87M | $153.91M | $150.90M | $145.87M | $130.26M | $138.87M | $139.89M | $137.75M | $119.68M | $125.66M | $130.83M | $125.98M | $119.33M | $126.44M | $131.18M | $127.88M | $112.12M | $114.00M | $118.53M | $115.00M | $102.15M | $104.13M | $106.05M | $102.80M | $90.75M | $92.80M | $87.33M | $100.40M | $97.11M | $97.25M |
| Low Forecast | $144.13M | $152.08M | $149.10M | $144.13M | $128.71M | $137.21M | $138.23M | $136.11M | $119.49M | $125.65M | $130.83M | $125.98M | $118.90M | $126.34M | $129.62M | $126.36M | $110.78M | $114.00M | $118.53M | $115.00M | $102.15M | $104.13M | $106.05M | $102.80M | $90.75M | $92.80M | $87.33M | $100.40M | $97.11M | $97.25M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 13 | 7 | 6 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.99% | 1.05% | - | 1.10% | 1.14% | 1.12% | 1.10% | 1.12% | 1.11% | 1.12% | 1.13% | 1.13% | 1.21% | 1.06% | 1.05% | 1.06% | - | 1.04% |
Exponent's average Quarter revenue forecast for Mar 24 based on 1 analysts is $125.98M, with a low forecast of $125.98M, and a high forecast of $125.98M. EXPO's average Quarter revenue forecast represents a -46.79% decrease compared to the company's last Quarter revenue of $236.77M (Dec 23).
Exponent EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 13 | 7 | 6 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $18.39M | $33.93M | - | $29.12M | $22.04M | $36.81M | $45.28M | $36.72M | $30.20M | $34.03M | $31.01M | $25.71M | $28.71M | $22.10M | $10.82M | $37.77M | - | $26.88M |
| Avg Forecast | $34.96M | $36.88M | $36.16M | $34.96M | $31.22M | $33.28M | $33.52M | $33.01M | $28.83M | $30.29M | $31.54M | $27.24M | $28.72M | $30.47M | $31.44M | $24.76M | $30.37M | $26.09M | $27.12M | $22.51M | $23.38M | $23.83M | $24.27M | $17.80M | $20.77M | $21.24M | $19.99M | $22.98M | $22.22M | $22.25M |
| High Forecast | $35.16M | $37.11M | $36.38M | $35.16M | $31.40M | $33.48M | $33.72M | $33.21M | $28.85M | $30.29M | $31.54M | $32.69M | $28.77M | $30.48M | $31.62M | $29.72M | $36.45M | $26.09M | $27.12M | $27.01M | $23.38M | $23.83M | $24.27M | $21.36M | $20.77M | $21.24M | $19.99M | $22.98M | $22.22M | $22.25M |
| Low Forecast | $34.75M | $36.66M | $35.94M | $34.75M | $31.03M | $33.08M | $33.32M | $32.81M | $28.81M | $30.29M | $31.54M | $21.79M | $28.67M | $30.46M | $31.25M | $19.81M | $24.30M | $26.09M | $27.12M | $18.01M | $23.38M | $23.83M | $24.27M | $14.24M | $20.77M | $21.24M | $19.99M | $22.98M | $22.22M | $22.25M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.64% | 1.11% | - | 1.18% | 0.73% | 1.41% | 1.67% | 1.63% | 1.29% | 1.43% | 1.28% | 1.44% | 1.38% | 1.04% | 0.54% | 1.64% | - | 1.21% |
1 analysts predict EXPO's average Quarter EBITDA for Mar 24 to be $27.24M, with a high of $32.69M and a low of $21.79M. This is 48.09% upper than Exponent's previous annual EBITDA (Dec 23) of $18.39M.
Exponent Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 13 | 7 | 6 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $20.93M | $24.54M | - | $29.12M | $22.52M | $24.44M | $25.75M | $29.61M | $20.38M | $24.57M | $25.40M | $30.85M | $19.12M | $18.08M | $16.35M | $26.28M | - | $19.63M |
| Avg Forecast | $26.33M | $30.97M | $30.46M | $28.91M | $23.29M | $28.12M | $28.97M | $28.21M | $20.81M | $24.82M | $26.12M | $18.38M | $22.65M | $24.98M | $26.25M | $16.71M | $20.50M | $21.38M | $22.93M | $15.19M | $18.29M | $20.09M | $21.64M | $12.01M | $14.55M | $15.71M | $12.67M | $21.74M | $16.79M | $17.52M |
| High Forecast | $26.53M | $31.21M | $30.69M | $29.13M | $23.47M | $28.34M | $29.20M | $29.26M | $20.97M | $24.83M | $26.12M | $22.06M | $22.83M | $25.17M | $26.45M | $20.05M | $24.60M | $21.38M | $22.93M | $18.23M | $18.29M | $20.09M | $21.64M | $14.41M | $14.55M | $15.71M | $12.67M | $21.74M | $16.79M | $17.52M |
| Low Forecast | $26.12M | $30.73M | $30.22M | $28.68M | $23.11M | $27.90M | $28.75M | $26.65M | $20.65M | $24.82M | $26.12M | $14.71M | $22.15M | $24.47M | $26.05M | $13.37M | $16.40M | $21.38M | $22.93M | $12.15M | $18.29M | $20.09M | $21.64M | $9.61M | $14.55M | $15.71M | $12.67M | $21.74M | $16.79M | $17.52M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.98% | - | 1.74% | 1.10% | 1.14% | 1.12% | 1.95% | 1.11% | 1.22% | 1.17% | 2.57% | 1.31% | 1.15% | 1.29% | 1.21% | - | 1.12% |
Exponent's average Quarter net income forecast for Mar 24 is $18.38M, with a range of $14.71M to $22.06M. EXPO's average Quarter net income forecast represents a -12.17% decrease compared to the company's last Quarter net income of $20.93M (Dec 23).
Exponent SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 13 | 7 | 6 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $5.94M | $80.03M | - | $90.02M | $81.21M | $69.51M | $64.19M | $72.99M | $72.21M | $68.33M | $74.97M | $77.81M | $71.76M | $65.25M | $71.06M | $55.52M | - | $63.98M |
| Avg Forecast | $73.85M | $77.93M | $76.40M | $73.85M | $65.95M | $70.31M | $70.83M | $69.74M | $60.91M | $64.00M | $66.63M | $64.13M | $60.67M | $64.38M | $66.42M | $58.30M | $72.62M | $58.06M | $60.37M | $53.00M | $52.03M | $53.04M | $54.02M | $41.90M | $46.22M | $47.27M | $44.48M | $51.14M | $49.46M | $49.53M |
| High Forecast | $74.29M | $78.39M | $76.86M | $74.29M | $66.34M | $70.73M | $71.25M | $70.16M | $60.96M | $64.00M | $66.63M | $76.96M | $60.78M | $64.40M | $66.81M | $69.96M | $87.15M | $58.06M | $60.37M | $63.60M | $52.03M | $53.04M | $54.02M | $50.28M | $46.22M | $47.27M | $44.48M | $51.14M | $49.46M | $49.53M |
| Low Forecast | $73.41M | $77.46M | $75.94M | $73.41M | $65.55M | $69.89M | $70.40M | $69.32M | $60.86M | $64.00M | $66.63M | $51.30M | $60.56M | $64.35M | $66.02M | $46.64M | $58.10M | $58.06M | $60.37M | $42.40M | $52.03M | $53.04M | $54.02M | $33.52M | $46.22M | $47.27M | $44.48M | $51.14M | $49.46M | $49.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.10% | 1.24% | - | 1.54% | 1.12% | 1.20% | 1.06% | 1.38% | 1.39% | 1.29% | 1.39% | 1.86% | 1.55% | 1.38% | 1.60% | 1.09% | - | 1.29% |
Exponent's average Quarter SG&A projection for Mar 24 is $64.13M, based on 1 Wall Street analysts, with a range of $51.30M to $76.96M. The forecast indicates a 979.26% rise compared to EXPO last annual SG&A of $5.94M (Dec 23).
Exponent EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 13 | 7 | 6 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.41 | $0.48 | - | $0.57 | $0.44 | $0.47 | $0.50 | $0.56 | $0.39 | $0.47 | $0.48 | $0.59 | $0.36 | $0.35 | $0.31 | $0.50 | - | $0.37 |
| Avg Forecast | $0.51 | $0.60 | $0.59 | $0.56 | $0.45 | $0.54 | $0.56 | $0.55 | $0.40 | $0.48 | $0.51 | $0.47 | $0.44 | $0.48 | $0.51 | $0.55 | $0.40 | $0.41 | $0.45 | $0.52 | $0.35 | $0.39 | $0.42 | $0.42 | $0.28 | $0.30 | $0.25 | $0.42 | $0.33 | $0.34 |
| High Forecast | $0.51 | $0.60 | $0.59 | $0.56 | $0.45 | $0.55 | $0.57 | $0.57 | $0.41 | $0.48 | $0.51 | $0.47 | $0.44 | $0.49 | $0.51 | $0.56 | $0.40 | $0.41 | $0.45 | $0.52 | $0.35 | $0.39 | $0.42 | $0.42 | $0.28 | $0.30 | $0.25 | $0.42 | $0.33 | $0.34 |
| Low Forecast | $0.51 | $0.60 | $0.59 | $0.56 | $0.45 | $0.54 | $0.56 | $0.52 | $0.40 | $0.48 | $0.51 | $0.47 | $0.43 | $0.47 | $0.50 | $0.55 | $0.39 | $0.41 | $0.45 | $0.52 | $0.35 | $0.39 | $0.42 | $0.42 | $0.28 | $0.30 | $0.25 | $0.42 | $0.33 | $0.34 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | 0.99% | - | 1.03% | 1.11% | 1.13% | 1.12% | 1.09% | 1.10% | 1.21% | 1.14% | 1.40% | 1.27% | 1.15% | 1.26% | 1.18% | - | 1.09% |
According to 1 Wall Street analysts, Exponent's projected average Quarter EPS for Mar 24 is $0.47, with a low estimate of $0.47 and a high estimate of $0.47. This represents a 13.71% increase compared to EXPO previous annual EPS of $0.41 (Dec 23).
Exponent Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| FC | Franklin Covey | $37.63 | $77.50 | 105.95% | Buy |
| RGP | Resources Connection | $8.37 | $13.00 | 55.32% | Buy |
| FCN | FTI Consulting | $196.77 | $275.00 | 39.76% | Hold |
| ICFI | ICF | $126.40 | $155.00 | 22.63% | Buy |
| HURN | Huron Consulting Group | $120.50 | $140.00 | 16.18% | Buy |
| EXPO | Exponent | $93.78 | $104.00 | 10.90% | Hold |
| CRAI | CRA | $206.55 | $194.00 | -6.08% |